Mar 27, 2020 · CAMBRIDGE, Mass., Feb. 27, 2020 -- Intellia Therapeutics, Inc. (NTLA), a leading genome editing company focused on developing curative therapeutics using CRISPR/Cas9 technology both in vivo and ex vivo, today reported operational highlights and financial results for the fourth quarter and year ended December 31, 2019. NTLA:London Stock Quote - Intellia Therapeutics Inc ... Stock analysis for Intellia Therapeutics Inc (NTLA:London) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Intellia Therapeutics, Inc. - TheStreet Intellia therapeutics (ntla) ceo bermingham explains the future of gene-editing on cnbc. By Lindsay Rittenhouse. Jul 28, 2016 4:12 PM EDT. OPINION. What you need to know about biotech ipos this year.
NTLA - Intellia Thera CS Stock Price - Barchart.com
In depth view into NTLA (Intellia Therapeutics) stock including the latest price, news, dividend history, earnings information and financials. 20 Mar 2020 Intellia Therapeutics, Inc. is a genome editing company. The Company is focused on developing therapeutics utilizing a biological tool known View the real-time NTLA price chart on Robinhood and decide if you want to buy or sell commission-free. Change the date range, see whether others are buying Get detailed information on INTELLIA THERAPEUTICS INC (NTLA.NQ) including stock quotes, financial news, historical charts, company background, company Company Name: Intellia Therapeutics Inc., Stock Symbol: NTLA, Industry: Biotechs, Total Posts: 7, Last Post: 1/8/2018 1:50:15 PM. NTLA Detailed Quote
NTLA: Intellia Therapeutics Inc - Stock Price, Quote and ...
Get detailed information on INTELLIA THERAPEUTICS INC (NTLA.NQ) including stock quotes, financial news, historical charts, company background, company Company Name: Intellia Therapeutics Inc., Stock Symbol: NTLA, Industry: Biotechs, Total Posts: 7, Last Post: 1/8/2018 1:50:15 PM. NTLA Detailed Quote Stock Quote. NASDAQ: NTLA. $11.14. Apr 1, 2020 4:00 PM EDT. Change; 0 ( 0.00%): Volume; 0: Today's Open; --: Previous Close; $11.14. Today's High; $12.53 Dividend History for Intellia Therapeutics Inc (NASDAQ:NTLA). Click to see Stock Price Quote detail and other financial information on NTLA, or here to see Information about which ETFs are holding the stock NTLA, Intellia Therapeutics Inc, from ETF Channel.
Real-time trade and investing ideas on Intellia Therapeutics NTLA from the largest community of traders and investors. ST Invest is a wholly owned subsidiary of StockTwits, Inc. Investing in securities products involves risk, including possible loss of principal.
Intellia Therapeutics, Inc. (NTLA) Stock Forum ... Find the latest Intellia Therapeutics, Inc. (NTLA) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors.
Learn about NTLA with our data and independent analysis including price, star rating, valuation, dividends, and financials. Start a 14-day free trial to Morningstar Premium to unlock our take on NTLA.
Intellia Therapeutics, Inc. - NTLA - Stock Price Today - Zacks View Intellia Therapeutics, Inc. NTLA investment & stock information. Get the latest Intellia Therapeutics, Inc. NTLA detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.
NTLA:London Stock Quote - Intellia Therapeutics Inc ...